Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)

NGX:NEIMETH Revenue

Neimeth International Pharmaceuticals had revenue of 2.34B NGN in the quarter ending September 30, 2026, with 11.71% growth. This brings the company's total for the last twelve months to 8.37B, up 30.76% year-over-year. In the year 2025, Neimeth International Pharmaceuticals had annual revenue of 7.37B with 64.29% growth. That makes Neimeth International Pharmaceuticals the 39,264th largest company in the world by revenue and 90th in Nigeria.

• Revenue (ttm): 8.37B
• Revenue Growth: +30.76%
• P/S Ratio: 3.82
• Revenue / Employee: 39.48M
• Employees: 212
• Market Cap: 31.99B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Pharmaceuticals 7.18B 97.5%
• Animal Health 187.55M 2.5%

Fiscal year ended Dec 31, 2025 See the full NGX:NEIMETH breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	7.37B	2.88B	64.29%
Dec 31, 2024	4.49B	2.28B	102.98%
Dec 31, 2023	2.21B	-709.73M	-24.31%
Dec 31, 2022	2.92B	216.47M	8.01%
Sep 30, 2022	2.70B	-343.81M	-11.28%

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error